
Dr. Agarwal’s Health Care Limited, a leading eye-care provider, operates 193 facilities in India and 16 in 9 African countries, using a hub-and-spoke model for efficient care delivery. With a 25% share in India’s organized eye-care market (FY24), it treated .16 crores patients in H1FY25 and conducted 140,787 surgeries. The Indian eye-care market, projected to grow at a 12-14% CAGR to ₹550-650 Bn by FY28, offers vast potential, with organized players comprising just 13-15%. Expansion in Tier-II/III cities and Africa positions the company for growth.
Bidding starts for all investor categories
Last day to place your bid
Share allotment finalised
Refunds credited for non-allottees
Allotted shares credited to demat account
Shares list on NSE / BSE
Post-close dates are indicative as per SEBI T+3 listing framework and may change per registrar updates.
| Investor Type | Min Lots | Min Shares | Min Amount | Max Lots | Max Amount | Notes |
|---|---|---|---|---|---|---|
| Retail | 1 | 35 | ₹14,070 | 14 | ₹196,980 | ≤ ₹2,00,000 |
| sHNI (Small HNI) | 15 | 525 | ₹211,050 | 71 | ₹998,970 | ₹2L – ₹10L |
| bHNI (Big HNI) | 72 | 2520 | ₹1,013,040 | 77 | ₹1,083,390 | > ₹10L |
| Category | Reservation | Shares Offered | Amount (₹ Cr) | Shares Bid | Subscribed | Allotment % |
|---|---|---|---|---|---|---|
| QIB | 50% | 38,609,694 | 1513.5 | 0 | 0.00x | 100% |
| NII | 15% | 11,582,908 | 454.05 | 0 | 0.00x | 100% |
| Retail | 35% | 27,026,786 | 1059.45 | 0 | 0.00x | 100% |
Retail is a lottery-based allotment when oversubscribed; QIB/NII get pro-rata. Probability ≈ 1 / subscription times (100% if under-subscribed).